On March 29, 2020 the U.S. Department of Health and Human Services issued a statement that they have “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
The HHS further explained that they will accept additional donations for COVID-19 treatment and trials. The HHS believes the use of donated medications will help to alleviate some of the medication shortages and shortage concerns that people have had since the initial announce of hydroxychloroquine and chloroquine were potential treatments for COVID-19
The FDA is working with drug manufactures to increase production to continue to meet the demands of those who are currently prescribed these medications for non-COVID related medical conditions.
Dr. Rohit Aggarwal, Chair of TMA’s Medical Advisory Board, recommends, “If you are currently prescribed plaquenil, reach out to your doctor to develop the best plan of care in case there is a shortage in your area while supplies are being replenished.”
Dr. Aggarwal says, “Reminder to check all of your prescriptions for refills. If they are getting close or due, work with your physician, pharmacist, and insurance company to refill now. Many pharmacies are providing 90-day supplies of medication. Check with your doctor to see if this is an appropriate treatment plan for you.”